Northern Star Resources (ASX:NST) wrapped up its $6 billion takeover of developer De Grey Mining (ASX:DEG) earlier this month ...

As Nanosonics scores FDA De Novo win, investors are now watching EMVision’s brain scanner in its US trials with Mayo Clinic.

ASX biotechs have become well-known for paediatric drug discovery with several life-altering treatments exported to the world.

Cosette Pharmaceutical's $600 million offer for Mayne Pharma looks imperilled after the bidder raised concerns about "adverse ...

They take moments to make but fake receipts created on popular AI tools like ChatGPT are costing companies and the economy ...

Buxton Resources is reinforcing the quest to conquer Centurion iron-oxide copper-gold project in WA with plans in hand for ...

Many Peaks Minerals has received broad high-grade results from Ouarigue South prospect of the Ferké gold project in Côte ...

With an expanded product portfolio, Avita Medical is on a concerted US push to win market share and become profitable by the end of the year ...

The RBA has cut rates as expected, delighting investors who piled into growth stocks in Info Tech and Finance sectors.

The ASX has climbed on the back of the RBA rate cut, but investors have one eye on oil as strike fears out of Israel rattle nerves.

The ASX has lifted in a broad rally across 9 of 11 sectors, pushed higher by strength in gold, energy and banking stocks.

ASX climbs 0.75pc out of the gate as markets bet on even chance of 50-bp interest rate cut from the RBA's rate decision today ...